MARKET

GNCA

GNCA

Genocea
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.580
-0.150
-5.49%
Closed 16:00 01/17 EST
OPEN
2.780
PREV CLOSE
2.730
HIGH
2.780
LOW
2.500
VOLUME
290.10K
TURNOVER
--
52 WEEK HIGH
11.28
52 WEEK LOW
1.990
MARKET CAP
80.95M
P/E (TTM)
-1.3595
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of GNCA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

GNCA News

  • Genocea Biosciences Inc (GNCA): Hedge Fund Sentiment Unchanged
  • Insider Monkey.12/15/2019 02:43
  • Benzinga's Top Upgrades, Downgrades For November 15, 2019
  • Benzinga.11/15/2019 14:59
  • Stifel likes Illumina in premarket analyst action
  • Seeking Alpha - Article.11/15/2019 13:49
  • SVB Leerink Initiates Coverage On Genocea Biosciences with Outperform Rating
  • Benzinga.11/15/2019 11:51

More

Industry

Biotechnology & Medical Research
-0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About GNCA

Genocea Biosciences, Inc. is a biopharmaceutical company developing personalized cancer immunotherapies. The Company’s Antigen Lead Acquisition System (ATLAS) technology platform allows to identify targets based on each person’s tumor antigen-specific T cell responses. Using ATLAS, the Company can improve neoantigens for inclusion in its immunotherapies and exclude inhibitory antigens that exert an immunosuppressive effect on anti-tumor immune responses. It provides GEN-009 program, which is a neoantigen vaccine candidate. The Company is conducting a Phase 1/2a clinical trial across a range of solid tumor types. It also provides GEN-011, which is a neoantigen-specific adoptive T cell therapy.
More

Webull offers Genocea Biosciences Inc (GNCA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.